Cure8 research brief
The appendix in conventional UC appears to be inflamed early and then remodels to fibrous obliteration over decades, which could influence thinking about timing or rationale for appendectomy-based interventions.
The lack of appendiceal inflammation in PSC-UC highlights biological differences between these patient groups.
Clinicians treating UC, colorectal surgeons, researchers studying UC pathophysiology or appendectomy-based therapies, and newly diagnosed UC patients interested in disease mechanisms.
The researchers reviewed appendices from patients who had total colectomy and compared histology by disease duration. In conventional UC, most appendices showed either active inflammation or fibrous obliteration; active inflammation was common within 5 years of diagnosis, whereas complete fibrous obliteration was common after 20 years.
When a red patch was seen on preoperative endoscopy, tissue showed a continuity from fibrous changes to active inflammation along the same appendix. The study suggests appendiceal inflammation may be more relevant early in conventional UC and raises the possibility that appendectomy-related approaches could have different effects depending on disease stage.
By contrast, PSC-associated UC cases in this series lacked appendiceal inflammation, supporting different disease biology.
This is a retrospective two-centre study of colectomy specimens (selected surgical population). Structured content depth is abstract-based; Cure8 did not review the full paper beyond the provided text.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The report suggests adding acupuncture to anti-TNF therapy may improve short-term symptom control and mucosal healing and reduce early colectomy risk for a TCM-defined subgroup of ulcerative colitis patients, which could...
Shows real-world long-term outcomes in a large Chinese UC cohort and highlights that baseline disease activity predicts need for escalation and colectomy risk; points to opportunities to improve treat-to-target care.
People with longstanding ulcerative colitis face higher colorectal cancer risk; this project focuses on a specific immune/stromal cell population (ST2+ cells responding to IL-33) that may help explain how chronic...
